Skip to main content
. 2021 May 6;9(5):467. doi: 10.3390/vaccines9050467

Table 2.

Efficacy of adenovirus-based and mRNA-based COVID-19 vaccines.

Vaccine Type RCT Phase Number Studies Efficacy (%) 95% CI (%) Included Case N Heterogeneity Test, p-Value
Lower Limit Upper Limit
Adenovirus-based 2/3 4 80.2 0.564 0.927 20771 <0.001
mRNA-based 2/3 2 94.6 0.936 0.954 34041 <0.001

RCT = randomized control trial.